Table 1.
Baseline characteristics of 389 patients with COVID‐19 pneumonia
| Total (n = 389) | Mild (n = 168) | Severe (n = 169) | Critical (n = 52) | |
|---|---|---|---|---|
| Age (years) | ||||
| Mean (s.d.) | 61·3 (13·8) | 56·7 (13·9) | 64·6 (12·2) | 65·4 (14·2) |
| Sex | ||||
| Male | 200 (51·4%) | 74 (44%) | 94 (55·6%) | 32 (61·5%) |
| Female | 189 (48·6%) | 94 (56%) | 75 (44·4%) | 20 (38·5%) |
| Signs and symptoms at admission | ||||
| Fever | 310 (79·7%) | 136 (81%) | 131 (77·5%) | 43 (82·7%) |
| Cough | 236 (60·7%) | 107 (64%) | 102 (60·4%) | 27 (51·9%) |
| Fatigue | 146 (37·5%) | 58 (34·5%) | 72 (42·6%) | 16 (30·8%) |
| Expectoration | 95 (24·4%) | 33 (19·6%) | 46 (27·2%) | 16 (30·8%) |
| Shortness of breath | 76 (19·5%) | 21 (12·5%) | 35 (20·7%) | 20 (38·5%) |
| Chest distress | 72 (18·5%) | 24 (14·3%) | 32 (18·9%) | 16 (30·8%) |
| Diarrhea | 44 (11·3%) | 22 (13·1%) | 16 (9·5%) | 6 (11·5%) |
| Muscle ache | 23 (5·9%) | 11 (6·5%) | 9 (5·3%) | 5 (9·6%) |
| Headache | 14 (3·7%) | 5 (3%) | 6 (3·6%) | 3 (5·8%) |
| Dizziness | 14 (3·7%) | 10·6% | 3 (1·8%) | 1 (1·9%) |
| Nausea and vomiting | 12 (3·0%) | 4 (2·4%) | 6 (3·6%) | 2 (3·8%) |
| Pharyngalgia | 10 (2·6%) | 7 (4·2%) | 3 (1·8%) | 0 |
| Chest pain | 10 (2·6%) | 5 (3%) | 2 (1·2%) | 3 (5·8%) |
| Comorbidities | 230 (59·1%) | 85 (50·6%) | 109 (64·5%) | 36 (69·2%) |
| Hypertension | 128 (32·9%) | 44 (26·2%) | 63 (37·3%) | 21 (40·4%) |
| Diabetes | 39 (10%) | 16 (9·5%) | 19 (11·2%) | 4 (7·7%) |
| Cardiovascular disease | 32 (8·2%) | 15 (8·9%) | 12 (7·1%) | 5 (9·6%) |
| Chronic kidney disease | 13 (3·3%) | 4 (2·4%) | 7 (4·1%) | 2 (3·8%) |
| Cerebrovascular disease | 8 (2·1%) | 3 (1·8%) | 3 (1·8%) | 2 (3·8%) |
| Malignancy | 4 (1%) | 2 (1·2%) | 2 (1·2%) | 0 |
| Chronic liver disease | 3 (0·8%) | 1 (0·6%) | 1 (0·6%) | 1 (1·9%) |
| COPD | 3 (0·8%) | 0 | 2 (1·2%) | 1 (1·9%) |
Data are presented as numbers (%) unless otherwise indicated. COVID‐19 = coronavirus disease‐2019; COPD = chronic obstructive pulmonary disease; s.d. = standard deviation.